Article
Influence of the LDL-Receptor Genotype on Statin Response in Heterozygous Familial Hypercholesterolemia: Insights From the Canadian FH Registry.
The Canadian journal of cardiology - 1 Mar 2022
Roy Gabrielle, Couture Patrick, Genest Jacques, Ruel Isabelle, Baass Alexis, Bergeron Jean, Brisson Diane, Brunham Liam R, Cermakova Lubomira, Gaudet Daniel, Khoury Etienne, Laflamme Nathalie, Kennedy Brooke A, Hegele Robert A, Drouin-Chartier Jean-Philippe
Abstract excerpt
BACKGROUND: Whether low-density lipoprotein (LDL) receptor (LDLR) residual activity influences the LDL-lowering effect of statins in heterozygous familial hypercholesterolemia (HeFH) remains unclear. The objective of this study was to investigate the relationship between the LDLR genotype and statin-induced LDL cholesterol (LDL-C) reductions in HeFH. METHODS: A total of 615 individuals with HeFH...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
